Skip to content
All compound profiles

EVIDENCE PROFILE / PUBLISHED

IGF-1 LR3

Long R3 IGF-I is an IGF-I analogue engineered for reduced binding to IGF-binding proteins; it is not ordinary recombinant human IGF-1. No adequate controlled human administration study was identified for this analogue in the reviewed source set.

Aliases reviewed
Long R3 IGF-I, LR3 IGF-1
Sources checked
2026-09-15
Editorial status
published

Evidence at a glance

Human
Not rated
Animal/cell
Not rated
Approved medicine
None foundScope: the sources reviewed.

Summarises how much research the profile's sources report, and of what kind. It is not a verdict on the compound or on any catalogue material.

PREPPY BOY ASKS

“A familiar name can hide a different molecule, fragment, formulation, or evidence story.”

The catalogue name is a starting point, not proof of formulation or identity. It is a laboratory probe for IGF-1 receptor signaling, growth, metabolism, and tissue responses.

Identity

Long R3 IGF-I is an IGF-I analogue engineered for reduced binding to IGF-binding proteins; it is not ordinary recombinant human IGF-1.

Biological mechanism or research interest

It is a laboratory probe for IGF-1 receptor signaling, growth, metabolism, and tissue responses.

Verified approved human uses

No approved human use for IGF-1 LR3 was verified in the reviewed sources; approvals for other IGF-1 medicines cannot be transferred.

Investigational human evidence

No adequate controlled human administration study was identified for this analogue in the reviewed source set.

Muscle-growth, recovery, and anti-aging claims are not demonstrated clinical outcomes.

Human versus animal or cell evidence

The cited guinea-pig and mouse/cell studies report tissue and metabolic effects that vary by model; the recent mouse study did not preserve cognition.

Limitations and known risks

Growth signaling raises unresolved hypoglycemia, organ-growth, and tumor-biology concerns; human dosing, pharmacokinetics, and long-term safety are not established.

What this profile is—and is not

Concise source review published with formulation, jurisdiction, and evidence-strength limits; recheck before material revision.

This is sourced education, not medical advice or a personal-use recommendation. It does not validate the identity, purity, sterility, safety, or effectiveness of a catalogue material.